About the Study

Type 1 Diabetes: A study of the oral medication DFMO in newly diagnosed type 1 diabetic children and adults for treatment.

This study is being done for children/adults: -Newly diagnosed (within past 100 days) type 1 diabetes -Ages 6-40 years DFMO is a medication taken by mouth which may reduce the stress of cells that make insulin and preserve body's own insulin production.

Interested in learning more?

Full Study Name: Tadpol